Groowe Groowe / Newsroom / NVO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVO News

Novo-Nordisk A/S

Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

globenewswire.com
NVO IONS PFE REGN LXRX VRTX LLY

Novo Nordisk introduces "There's Only One OzempicĀ®" campaign, reuniting Justin Long and John Hodgman

prnewswire.com
NVO

Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes

globenewswire.com
NVO

Lipovive Investigated (2026) Is Lipovive the Natural Ozempic? A Research-Based Look at Its Weight Loss Potential

globenewswire.com
NVO

Donovan Mackie turns pro with Team Novo Nordisk for 2026

prnewswire.com
NVO

Refills GLP-1 Weight Loss Guide 2026: Branded vs Compounded Options, Eligibility, Pricing Factors, and FDA Safety Notes

accessnewswire.com
NVO LLY

SkinnyRx GLP-1 Weight Loss Guide 2026: Injectable vs Sublingual vs Tablet Options (Semaglutide + Tirzepatide)

accessnewswire.com
NVO LLY

Germany's BMZ, Novo Nordisk Foundation, Rockefeller Foundation, and WFP Launch School Meals Accelerator to Feed 100 Million Children by 2030

prnewswire.com
NVO

Oral Protein and Peptides Market to Hit Valuation of US$ 47.33 Billion By 2035 | Astute Analytica

globenewswire.com
VKTX LLY NVO MRK FSK TSN KDP PEP MNDO THG ENTX RANI

Digbi Health Publishes Peer-Reviewed Data Demonstrating Significant Cost Savings for Employers Via Its Precision Biology Telehealth Platform to Manage GLP-1, Metabolic, and GI Costs

globenewswire.com
NVO LLY